This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Shilpa Medicare Limited. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2019
Title: Nagnnath Kokare: Innovator in Pharmaceutical Chemistry
Introduction
Nagnnath Kokare is a notable inventor based in Raichur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 3 patents to his name, Kokare's work is recognized for its impact on medical treatments.
Latest Patents
Kokare's latest patents include a process for the preparation of substantially pure vemurafenib and its salts. This invention relates to a method for creating a compound known as propane-1-sulfonic acid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, commonly referred to as Vemurafenib. Additionally, he has developed a process for preparing Echothiophate Iodide, which is obtained as a new crystalline form designated as Form-SET. This eco-friendly process avoids hazardous solvents and yields a high-purity product useful in treating ocular disorders like glaucoma.
Career Highlights
Kokare is currently employed at Shilpa Medicare Limited, where he continues to innovate in the pharmaceutical sector. His work has not only advanced the field but has also contributed to the development of safer and more effective treatments.
Collaborations
Some of his notable coworkers include Akshaykant Chaturvedi and Vinod Kumar Singh. Their collaborative efforts have further enhanced the research and development initiatives at Shilpa Medicare Limited.
Conclusion
Nagnnath Kokare's contributions to pharmaceutical chemistry exemplify the importance of innovation in medical science. His patents reflect a commitment to improving healthcare through advanced research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile